PTGS2 and colorectal cancer: In colorectal cancer, NSAIDs (indomethacin, sulindac, aspirin and celecoxib) could inhibit the formation of CSCs and reduce chemotherapy-induced CSCs via inhibiting COX-2 and NOTCH/HES1, and activating PPARγ (Moon et al., 2014).